Table 1. Potential biomarkers between TBEV patients and the healthy control group.

Lipid	p-value	Log2 (FC)	VIP	Trend
PC 36:5|PC 16:0_20:5	1.44E-14	10.54	6.43	↑
PC 28:3;1	4.33E-17	1.89	2.18	↑
PC 36:2;1	1.44E-12	8.07	5.03	↑
PC 38:3;2	1.60E-11	1.21	1.53	↑
PC 38:7	9.07E-15	9.67	6.48	↑
CE 18:3;1	4.4266E-19	3.65	3.15	↑
LPE O-16:1	2.88E-09	1.24	1.57	↑
TAG 60:10|TAG 18:0_20:4_22:6	0.001	−1.08	1.01	↓
PE O-37:5|PE O-17:1_20:4
TAG 60:11 TAG 16:0_22:5_22:6	2.46E-05	−1.10	1.03	↓
DAG 40:8|DAG 18:2_22:6	1.09E-05	−1.06	1.25	↓
PC 30:1	5.44E-05	1.02	1.27	↑
PC 38:3;2	3.02E-06	1.04	1.18	↑
PC 28:3;1	4.23E-13	2.04	2.15	↑
PC 36:5|PC 16:0_20:5	8.23E-39	10.54	6.51	↑
PC 38:7	4.84E-41	9.83	6.41	↑
CE 18:3;1	6.94E-18	3.68	2.93	↑
TAG 42:0|TAG 10:0_16:0_16:0	0.012673	1.20	1.17	↑
TAG 52:6	0.001648	−1.03	1.12	↓
LPE O-16:1	5.01E-9	1.34	1.63	↑
PC 36:2;1	3.02E-06	7.92	4.77	↑
TAG 54:7(18:2/18:2/18:3)	0.001	−1.17	1.13	↓
TAG 54:8|TAG 18:2_18:3_18:3	0.005	−1.66	1.44	↓
TAG 58:10(18:2/18:2/22:6)	0.0001	−1.04	1.14	↓
TAG 59:7	0.0001	−1.22	1.37	↓
DAG 40:8|DAG 18:2_22:6	6.56E-05	−1.08	1.20	↓